Objectivity and equity: clarity required. A response to Hill and Olson

Recommendations for the use of clinical outcome assessments in rare disease drug development.

EClinicalMedicine·2026

Estimating stage-specific lung cancer costs for economic evaluation of LDCT screening in Ireland: a patient-level microsimulation.

BMC health services research·2026

The association between antibiotic consumption and antimicrobial resistance-related mortality and costs: An analysis of European country-level data.

International journal of antimicrobial agents·2026

Estimating Eligibility for Lung Cancer Screening in Ireland: A Dynamic Modelling Study of Smoking Trends.

PharmacoEconomics - open·2026

The Inequality-Adjusted Incremental Cost-Effectiveness Ratio.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Development of the Medical Device Economic Evaluation Methodological Quality (DEEM-Q) Assessment Checklist.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Missing Data in Trial-Based Cost-Effectiveness Analysis: The Journey Continues.

PharmacoEconomics·2026

External Validation of SELECT Trial-Derived Cardiovascular Risk Equations in a UK Population with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes.

PharmacoEconomics·2026

A Machine Learning and Large Language Model Tool for Systematic Literature Reviews of Health Economic Evidence: A Validation Study.

PharmacoEconomics·2026

A Cost-Effectiveness Model of Semaglutide 2.4 mg, Resmetirom 80 mg, and Resmetirom 100 mg Versus Standard of Care for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis in the United States.

PharmacoEconomics·2026

Uncertainty in Economic Evaluation: A Pragmatic Guide for Health Technology Assessment (HTA) Agencies in Resource-Constrained Settings.

PharmacoEconomics·2026

Cost-Effectiveness and Budget Impact of Lung Cancer Screening: A Systematic Review.

PharmacoEconomics·2026

"There for the safety net, not the dreams": local decision-makers' perceptions on scarcity, trade-offs, and caregiving responsibilities in social care resource allocation in the Netherlands.

The Gerontologist·2026

Governing waste and producing environmental subjects: a sociological analysis of decentralised solid waste management model in Kerala, India.

Frontiers in sociology·2026

Hierarchical government environmental confidence and willingness to pay for environmental protection: evidence from urban-rural China.

Frontiers in public health·2026

Health Policy and Value Assessment Through the Health Equity Lens: How Far from Being Incorporated Routinely? An Environmental Scan of Frameworks and Policy Gaps.

Value in health regional issues·2026

Perceived HR practices and employee performance: mediating effects of affective commitment and moderating effects of transformational leadership.

Frontiers in sociology·2026

Adaptive competitive balance regulation in professional sports leagues via graph attention networks and proximal policy optimization.

Scientific reports·2026

Related Experiment Videos

Objectivity and equity: clarity required. A response to Hill and Olson

Related Concept Videos

Recommendations for the use of clinical outcome assessments in rare disease drug development.

Estimating stage-specific lung cancer costs for economic evaluation of LDCT screening in Ireland: a patient-level microsimulation.

The association between antibiotic consumption and antimicrobial resistance-related mortality and costs: An analysis of European country-level data.

Estimating Eligibility for Lung Cancer Screening in Ireland: A Dynamic Modelling Study of Smoking Trends.

The Inequality-Adjusted Incremental Cost-Effectiveness Ratio.

Development of the Medical Device Economic Evaluation Methodological Quality (DEEM-Q) Assessment Checklist.

Missing Data in Trial-Based Cost-Effectiveness Analysis: The Journey Continues.

External Validation of SELECT Trial-Derived Cardiovascular Risk Equations in a UK Population with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes.

A Machine Learning and Large Language Model Tool for Systematic Literature Reviews of Health Economic Evidence: A Validation Study.

A Cost-Effectiveness Model of Semaglutide 2.4 mg, Resmetirom 80 mg, and Resmetirom 100 mg Versus Standard of Care for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis in the United States.

Uncertainty in Economic Evaluation: A Pragmatic Guide for Health Technology Assessment (HTA) Agencies in Resource-Constrained Settings.

Cost-Effectiveness and Budget Impact of Lung Cancer Screening: A Systematic Review.

"There for the safety net, not the dreams": local decision-makers' perceptions on scarcity, trade-offs, and caregiving responsibilities in social care resource allocation in the Netherlands.

Governing waste and producing environmental subjects: a sociological analysis of decentralised solid waste management model in Kerala, India.

Hierarchical government environmental confidence and willingness to pay for environmental protection: evidence from urban-rural China.

Health Policy and Value Assessment Through the Health Equity Lens: How Far from Being Incorporated Routinely? An Environmental Scan of Frameworks and Policy Gaps.

Perceived HR practices and employee performance: mediating effects of affective commitment and moderating effects of transformational leadership.

Adaptive competitive balance regulation in professional sports leagues via graph attention networks and proximal policy optimization.

Related Experiment Videos

Objectivity and equity: clarity required. A response to Hill and Olson

Related Concept Videos

Related Articles